Close X
Get more out of
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.

Click here if you're interested
Helping you make better health choices

What Doctors Don't Tell You

In shops now or delivered to your home from only £3.50 an issue!

May 2020 (Vol. 5 Issue 3)

GSK fined for blocking antidepressant rivals
About the author: 
Bryan Hubbard

GSK fined for blocking antidepressant rivals image

Pharmaceutical giant GlaxoSmithKline (GSK) has been fined £37.6m after bribing competitors to delay the launch of their versions of GSK’s blockbuster drug, the antidepressant Seroxat (paroxetine).

GSK paid more than £50m to competitors—including Merck and Generics UK—who were also fined £7.4m by the UK’s Competition and Markets Authority (CMA). The companies were working on generic, and cheaper, versions of Seroxat, which had lost its patent protection.

The cash payments were made between 2002 and 2004, CMA investigators discovered. The competitors were allowed to launch small amounts of paroxetine, but not enough to impact on Seroxat sales or create a truly competitive and open market.

Once generics finally entered the market in 2013, the average price of paroxetine fell by 70 per cent.

The CMA’s Michael Grenfell said the decision “sends out a strong message that we will tackle illegal behaviour that is designed to stifle competition at the expense of customers—in this case the National Health Service and, ultimately, taxpayers”.

GSK is considering an appeal.


(Source: BBC, February 12, 2016)

You may also be interested in...

Support WDDTY

Help support us to hold the drugs companies, governments and the medical establishment accountable for what they do.


Latest Tweet


Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions..

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

© 2010 - 2019 WDDTY Publishing Ltd.
All Rights Reserved